Clinical Professor of Psychiatry
UC San Diego
San Diego, California
Carla Marienfeld, MD, DFAPA, FASAM is board-certified in psychiatry, addiction psychiatry, and addiction medicine, and she is a Clinical Professor at the University of California San Diego who supports recovery in an evidence based, harm-reduction approach through motivational interviewing and medication treatment. She was named a San Diego Top Doctor in 2021 as Medical Director for the UC San Diego Substance Treatment and Recovery (STAR) program. Her research involves populations with substance use disorders, including pregnant women and the development of their offspring, often using analysis of electronic medical record data. She has authored over three dozen peer reviewed articles, book chapters, practice guidelines, and invited commentaries, and she edited two books: Motivational Interviewing for Clinical Practice and Absolute Addiction Psychiatry Review: An essential board exam study guide. She has a record of grant funding for research and founding the UCSD Addiction Psychiatry Fellowship Program, where she serves as Program Director. She has been highly involved in the education of colleagues and trainees about addiction psychiatry, buprenorphine treatment, and motivational interviewing. Dr. Marienfeld completed a fellowship in addiction psychiatry and residency training in psychiatry at Yale. During her residency, she was chief resident of psychiatry and founded (and later led as junior faculty) the Yale Global Mental Health Program. She earned a medical degree with honors from Baylor College of Medicine in Houston. She is active in many professional organizations, including the American Society of Addiction Medicine, the American Association of Addiction Psychiatry, and the American Psychiatric Association.
Thursday, April 24, 2025
9:00 AM – 9:10 AM
Disclosure(s): CARI Health: Consultant/Advisory Board (Ongoing), Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing)
Thursday, April 24, 2025
9:20 AM – 9:50 AM
Disclosure(s): CARI Health: Consultant/Advisory Board (Ongoing), Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing)
Session 6: Medical Management of Acute Stimulant Intoxication
Thursday, April 24, 2025
2:45 PM – 3:35 PM
Disclosure(s): CARI Health: Consultant/Advisory Board (Ongoing), Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing)
Thursday, April 24, 2025
4:25 PM – 4:30 PM
Disclosure(s): CARI Health: Consultant/Advisory Board (Ongoing), Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing)
